Search result for: Biosimilar

September 2026

Biosimilar Monoclonal Antibody Market Size, Key Companies, Company Market Share, Patient Volume, Treatment Adoption Rates, Pricing Analysis, Regulatory Landscape, Competitive Positioning, and Demand Forecast

  • Report Code : 3400
  • Published : September 2026
  • Delivery : Immediate
  • Category : Healthcare
  • No. of Pages : 150+

The biosimilar monoclonal antibody market was valued at USD 19.73 billion in 2026, with leading companies including Roche, Mylan, Biogen.

September 2026

Biosimilars Market Size, Key Companies, Company Product Portfolio, Hospital Procurement Trends, Manufacturing Capacity, Sales Performance, Regulatory Approvals, Company Market Share, and Forecast

  • Report Code : 1359
  • Published : September 2026
  • Delivery : Immediate
  • Category : Healthcare
  • No. of Pages : 150+

The global biosimilars market size is exhibited at USD 47.36 billion in 2026 and is projected to hit around USD 191.29 billion by 2035, growing at a solid CAGR of 16.84%.

September 2026

Biologics and Biosimilars Market Size, Companies, Share, Patient Volume, Treatment Adoption Rates, Pricing Analysis, Regulatory Landscape, Competitive Positioning, and Demand Forecast

  • Report Code : 8097
  • Published : September 2026
  • Delivery : Immediate
  • Category : Healthcare
  • No. of Pages : 150+

The global biologics and biosimilars market size is estimated to hit around USD 2,426.85 billion by 2035 increasing from USD 700.76 billion in 2026, with a CAGR of 14.80%.

June 2026

Immunology Biosimilars Market Size, Key Companies, Company Market Share, Patient Volume, Treatment Adoption Rates, Pricing Analysis, Regulatory Landscape, Competitive Positioning, and Demand Forecast

  • Report Code : 5935
  • Published : June 2026
  • Delivery : Immediate
  • Category : Healthcare
  • No. of Pages : 150+

The global immunology biosimilars market size was estimated at USD 13.24 billion in 2026 and is expected to hit around USD 56.39 billion by 2035, growing at a CAGR of 17.51%.

June 2026

Psoriasis Biosimilars Market Size, Share and Trends 2026 to 2035

  • Report Code : 5163
  • Published : June 2026
  • Delivery : Immediate
  • Category : Healthcare
  • No. of Pages : 150+

The global psoriasis biosimilars market size is evaluated at USD 10.46 billion in 2025 and is projected to attain around USD 29.78 billion by 2035, with a CAGR of 11.03%.

For Any Query

Please drop a mail to the Precedence Research team for your queries

Contact Us

Categories

Quick Contact

call +1 650 460 3308 call +61 485 981 310
+91 87933 22019 call +44 7383 092 044 mail sales@precedenceresearch.com

Connect with us now; your solution awaits on the other side!

Contact Us